These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28622247)

  • 1. Effects of Portal Hypertension on Gadoxetic Acid-Enhanced Liver Magnetic Resonance: Diagnostic and Prognostic Implications.
    Asenbaum U; Ba-Ssalamah A; Mandorfer M; Nolz R; Furtner J; Reiberger T; Ferlitsch A; Kaczirek K; Trauner M; Peck-Radosavljevic M; Wibmer AG
    Invest Radiol; 2017 Aug; 52(8):462-469. PubMed ID: 28622247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters.
    Bastati N; Wibmer A; Tamandl D; Einspieler H; Hodge JC; Poetter-Lang S; Rockenschaub S; Berlakovich GA; Trauner M; Herold C; Ba-Ssalamah A
    Invest Radiol; 2016 Nov; 51(11):728-734. PubMed ID: 27175548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
    Bastati N; Beer L; Mandorfer M; Poetter-Lang S; Tamandl D; Bican Y; Elmer MC; Einspieler H; Semmler G; Simbrunner B; Weber M; Hodge JC; Vernuccio F; Sirlin C; Reiberger T; Ba-Ssalamah A
    Radiology; 2020 Jan; 294(1):98-107. PubMed ID: 31743083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging.
    Wibmer A; Prusa AM; Nolz R; Gruenberger T; Schindl M; Ba-Ssalamah A
    Radiology; 2013 Dec; 269(3):777-86. PubMed ID: 23942606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: Preliminary results.
    Wagner M; Hectors S; Bane O; Gordic S; Kennedy P; Besa C; Schiano TD; Thung S; Fischman A; Taouli B
    J Magn Reson Imaging; 2018 Oct; 48(4):1091-1103. PubMed ID: 29638020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of postoperative liver failure using gadoxetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Jin YJ; Lee SH; Cho SG; Kim JH; Lee JW; Lee KY; Shin WY
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1349-56. PubMed ID: 26916616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol.
    Kühn JP; Hegenscheid K; Siegmund W; Froehlich CP; Hosten N; Puls R
    AJR Am J Roentgenol; 2009 Nov; 193(5):1318-23. PubMed ID: 19843748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase.
    Torrisi C; Picone D; Cabibbo G; Matranga D; Midiri M; Brancatelli G
    Eur J Radiol; 2018 Oct; 107():39-45. PubMed ID: 30292271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.
    Bastati N; Beer L; Ba-Ssalamah A; Poetter-Lang S; Ambros R; Kristic A; Lauber D; Pomej K; Binter T; Simbrunner B; Semmler G; Balcar L; Bican Y; Hodge JC; Wrba T; Trauner M; Reiberger T; Mandorfer M
    J Hepatol; 2022 Oct; 77(4):1005-1013. PubMed ID: 35525337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.
    Hwang J; Kim YK; Jeong WK; Choi D; Rhim H; Lee WJ
    Radiology; 2015 Jul; 276(1):137-46. PubMed ID: 25734551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Transient Motion During Gadoxetic Acid-Enhanced Multiphasic Liver Magnetic Resonance Imaging Using Free-Breathing Golden-Angle Radial Sparse Parallel Magnetic Resonance Imaging.
    Yoon JH; Lee JM; Yu MH; Hur BY; Grimm R; Block KT; Chandarana H; Kiefer B; Son Y
    Invest Radiol; 2018 Jan; 53(1):52-61. PubMed ID: 28902723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging liver fibrosis in chronic hepatitis B with T
    Yang L; Ding Y; Rao S; Chen C; Wu L; Sheng R; Fu C; Zeng M
    J Magn Reson Imaging; 2017 Apr; 45(4):1186-1194. PubMed ID: 27563840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does injection flow rate have an impact on arterial phase image degradation in liver MRI? A comparison of gadoxetic acid versus gadobutrol.
    Cohen-Hallaleh V; Guo L; Hosseini-Nik H; Razaghi Kashani N; Menezes R; Jhaveri K
    Clin Radiol; 2017 Nov; 72(11):994.e1-994.e8. PubMed ID: 28673445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma: Diagnostic Accuracy of Gadoxetic Acid-enhanced MR Imaging.
    Kim JH; Lee JM; Yoon JH; Lee DH; Lee KB; Han JK; Choi BI
    Radiology; 2016 Jun; 279(3):773-83. PubMed ID: 26780538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Feasibility of Free-Breathing Dynamic T1-Weighted Imaging With Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging Using a Combination of Variable Density Sampling and Compressed Sensing.
    Yoon JH; Yu MH; Chang W; Park JY; Nickel MD; Son Y; Kiefer B; Lee JM
    Invest Radiol; 2017 Oct; 52(10):596-604. PubMed ID: 28492418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of liver proton density fat fraction and changes in R 2* measurements induced by administering gadoxetic acid at 3T MRI.
    Sofue K; Zhong X; Nickel MD; Dale BM; Bashir MR
    Abdom Radiol (NY); 2016 Aug; 41(8):1555-64. PubMed ID: 27052456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver-fat and liver-function indices derived from Gd-EOB-DTPA-enhanced liver MRI for prediction of future liver remnant growth after portal vein occlusion.
    Barth BK; Fischer MA; Kambakamba P; Lesurtel M; Reiner CS
    Eur J Radiol; 2016 Apr; 85(4):843-9. PubMed ID: 26971433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid.
    Ichikawa S; Motosugi U; Omiya Y; Onishi H
    Invest Radiol; 2017 Jul; 52(7):389-395. PubMed ID: 28195932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual Crossover Comparison of Gadoxetic Acid Dose for Liver MRI in Normal Volunteers.
    Motosugi U; Bannas P; Hernando D; Salmani Rahimi M; Holmes JH; Reeder SB
    Magn Reson Med Sci; 2016; 15(1):60-72. PubMed ID: 26104082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.